SCHEMBL2262397

SCHEMBL2262397

O=P(O)(O)OP(O)(=S)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8534675 0.86 FDPS (0.45)
SCHEMBL2457995 0.84 FDPS (0.43)
SCHEMBL3411983 0.79
Triphosphate SCHEMBL29692 0.79 FDPS (0.50)
Pyrophosphoric Acid SCHEMBL28447258 0.76 FDPS (0.77)
SCHEMBL2262400 0.76
Pyrophosphoric Acid SCHEMBL5391541 0.75 FDPS (0.91)
SCHEMBL8534046 0.75 FDPS (0.45)
SCHEMBL11402357 0.75 FDPS (0.45)
SCHEMBL23493052 0.73 FDPS (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025233518-A1 CROSSING THE BLOOD BRAIN BARRIER TO TREAT DISEASES OF THE BRAIN HARBOUR ANTIBODIES BV (NL) 2025-11-13 WO claimed
EP-0289909-B1 ALL AQUEOUS FORMULATIONS OF ORGANO-PHOSPHOROUS PESTICIDES BASF Corporation (US) 1992-09-16 EP claimed
US-12637682-B2 Protein translational control THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2026-05-26 US disclosed
EP-4731241-A1 BRICK1 FOR USE IN TREATING MYOCARDIAL DISEASES Medizinische Hochschule Hannover (DE) 2026-04-29 EP disclosed
US-20260028677-A1 Compositions and Methods for Modulating Genetic Drivers FLAGSHIP PIONEERING INNOVATIONS VII LLC (US) 2026-01-29 US disclosed
US-20260002204-A1 METHOD FOR PRODUCING SPACER-SPECIFIC DNA RECOMBINING ENZYMES TECHNISCHE UNIV DRESDEN KOERPERSCHAFT DES OEFFENTLICHEN RECHTS (DE) 2026-01-01 US disclosed
US-20250353906-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS FLAGSHIP PIONEERING INNOVATIONS VII LLC (US) 2025-11-20 US disclosed
EP-4650780-A2 COMPOSITIONS AND METHODS FOR MODULATING CIRCULATING FACTORS Flagship Pioneering Innovations VII, LLC (US) 2025-11-19 EP disclosed
WO-2025233518-A1 CROSSING THE BLOOD BRAIN BARRIER TO TREAT DISEASES OF THE BRAIN HARBOUR ANTIBODIES BV (NL) 2025-11-13 WO disclosed
EP-4640849-A2 COMPOSITIONS AND METHODS FOR MODULATING GENETIC DRIVERS Flagship Pioneering Innovations VII, LLC (US) 2025-10-29 EP disclosed
EP-4641201-A2 COMPOSITIONS AND METHODS FOR MODULATION OF TUMOR SUPPRESSORS AND ONCOGENES Flagship Pioneering Innovations VII, LLC (US) 2025-10-29 EP disclosed
US-8003576-B2 Friction modifier for drilling fluids THE LUBRIZOL CORPORATION (US) 2011-08-23 US disclosed
WO-2010071784-A1 FRICTION MODIFIER FOR DRILLING FLUIDS PQ CORPORATION (US) 2010-06-24 WO disclosed
US-20100152067-A1 FRICTION MODIFIER FOR DRILLING FLUIDS THE LUBRIZOL CORPORATION 2010-06-17 US disclosed
US-5750666-A FOR SYNTHESIZING NEW MONONUCLEOTIDES AND POLYNUCLEOTIDES HAVING PHOSPHOROTHIOATE AND PHOSPHORODITHIOATE INTERNUCLEOTIDE LINKAGES COMPETITVE TECHNOLOGIES, INC. (US) 1998-05-12 US disclosed
US-5684148-A NUCLEOSIDES AND POLYNUCLEOTIDES AS FLUORESCENT AGENTS FOR MEDICAL DIAGNOSIS COMPETITIVE TECHNOLOGIES, INC. (US) 1997-11-04 US disclosed
US-5602244-A DINUCLEOSIDE PRECURSORS IN OLIGONUCLEOTIDE SYNTHESIS; USEFUL AS ANTISENSE INHIBITORS OF TRANSLATION COMPETITIVE TECHNOLOGIES, INC. (US) 1997-02-11 US disclosed
US-5218103-A Nucleoside thiophosphoramidites UNIVERSITY PATENTS, INC. (US) 1993-06-08 US disclosed
WO-1991004983-A1 NUCLEOSIDE AND POLYNUCLEOTIDE THIOPHOSPHORAMIDITE AND PHOSPHORODITHIOATE COMPOUNDS AND PROCESSES UNIVERSITY PATENTS, INC. (US) 1991-04-18 WO disclosed
EP-0016383-B1 OXADIAZOLYLMETHYLTHIOL PHOSPHATES, METHODS OF THEIR PRODUCTION AND THEIR USE IN COMBATING PESTS BASF Aktiengesellschaft (DE) 1982-05-26 EP disclosed